Patent: 6,930,090
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Summary for Patent: 6,930,090
Title: | Methods of activating a receptor using amphiphilic drug-oligomer conjugates |
Abstract: | The present invention relates to amphiphilic drug-oligomer conjugates capable of traversing the blood-brain barrier (\"BBB\") and to methods of making and using such conjugates. An amphiphilic drug-oligomer conjugate comprises a therapeutic compound conjugated to an oligomer, wherein the oligomer comprises a lipophilic moiety coupled to a hydrophilic moiety. The conjugates of the invention further comprise therapeutic agents such as proteins, peptides, nucleosides, nucleotides, antiviral agents, antineoplastic agents, antibiotics, etc., and prodrugs, precursors, derivatives and intermediates thereof, chemically coupled to amphiphilic oligomers. |
Inventor(s): | Ekwuribe; Nnochiri N. (Cary, NC), Radhakrishnan; Balasingam (Chapel Hill, NC), Price; Christopher H. (Chapel Hill, NC), Anderson, Jr.; Wes (Raleigh, NC), Ansari; Aslam M. (Durham, NC) |
Assignee: | Nobex Corporation (Durham, NC) |
Application Number: | 10/716,975 |
Patent Claims: | see list of patent claims |
Details for Patent 6,930,090
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Recordati Rare Diseases, Inc. | ELSPAR | asparaginase | For Injection | 101063 | 01/10/1978 | ⤷ Try a Trial | 2018-08-14 |
Nps Pharmaceuticals, Inc. | NATPARA | parathyroid hormone | For Injection | 125511 | 01/23/2015 | ⤷ Try a Trial | 2018-08-14 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |